News 24 | What is the history of the drug “Stromifab” which, according to the United Arab Emirates, has successfully treated patients with Corona?

Many countries are testing – with the vaccine – many drugs to treat patients infected with the Corona virus, such as dexamethasone and stromefab, the latter having been approved by the United States Food and Drug Administration for the treatment of emergency of corona patients.

And the UAE health authorities have announced the success of the drug “Stromifab” in treating patients with the Corona virus, after 13,000 people infected with the virus were completely cured in 14 days.

Here we review the information about treatment with this drug, its side effects, and the extent to which it is recommended.

Stromifab is treated with antibodies and was developed by GlaxoSmithKline and Fair Bio Technology in America, to treat mild and moderate cases of people 12 years of age and older infected with the virus.

Stromifab belongs to a class of drugs that use monoclonal antibodies, which mimic the natural antibodies the body makes to fight infection.

Stromefab is similar to two other drugs approved by the US Drug Regulatory Administration, which are “Regen-Cove-2”, for the company “Regeneron”, which was used to treat former US President Donald Trump, and the treatment of the company “Eli Lilly”, which has reduced hospitalizations and deaths. by 70%.

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive scientific opinion that the medicine can be used to treat adults and adolescents with coronavirus, who do not need oxygen supplementation and who present a risk of serious symptoms.

The most common side effects of the drug were rash and diarrhea, which were all mild or moderate, and no adverse symptoms resulting from treatment were reported, at a higher rate than placebo, but there is a hypersensitivity warning.

Studies have shown that the drug prevents disease progression to severe cases or death in over 85% of cases with early treatment, and it can treat all mutated forms known to date.

Health authorities in the United Arab Emirates were among the first to receive the drug “Stromifab” globally, after studies showed that its success in preventing the development of the virus was a 97% cause of death.